Any planned research project to be conducted in California that requires the use of a Schedule I or Schedule II Controlled Substance (NO Schedule III, IV, and V) as its main study drug, including comparison drug(s), or research on the treatment of controlled substance use disorder, should be submitted to the Research Advisory Panel of California for review and approval.
Research is categorized into 4 groups:
Group 1: Academic human research of Schedule I or Schedule II controlled substances - See Application Forms
Group 2: Human research on the treatment of controlled substance use disorder utilizing ANY scheduled or non-scheduled medications. Academic research studies see - Application Forms. Clinical drug trial research studies see - Clinical Drug Trials
Group 3: Non-human research with animal models OR in-vitro studies of Schedule I controlled substances only - See Application Forms
Group 4: Multi or single center clinical drug trial research sponsored by a pharmaceutical company/CRO evaluating or comparing any Schedule I and II controlled substances - See Clinical Drug Trials
Submission Requirements for each group: